0

Journal Articles

in Conflict of Interest
 41-60 of 84 Articles
JAMA | 
Special Communication |  April 01, 2009
Professional Medical Associations and Their Relationships With Industry:  A Proposal for Controlling Conflict of Interest
David J. Rothman, PhD; Walter J. McDonald, MD; Carol D. Berkowitz, MD; et al.
JAMA. 2009;301(13):1367-1372. doi:10.1001/jama.2009.407.
JAMA | 
Medical News & Perspectives |  March 18, 2009
JAMA Editor Honored as Champion of Integrity in Scientific Research and Publishing
Rebecca Voelker
JAMA. 2009;301(11):1117. doi:10.1001/jama.301.11.1117.
JAMA | 
Medical News & Perspectives |  February 18, 2009
Report: FDA Exerts Too Little Oversight of Researchers’ Conflicts of Interest
Bridget M. Kuehn
JAMA. 2009;301(7):709-710. doi:10.1001/jama.2009.127.
JAMA | 
Commentary |  September 03, 2008
New Developments in Managing Physician-Industry Relationships
David J. Rothman, PhD; Susan Chimonas, PhD
JAMA. 2008;300(9):1067-1069. doi:10.1001/jama.300.9.1067.
JAMA | 
Capitol Health Call |  April 09, 2008
Consulting Conflicts
Mike Mitka
JAMA. 2008;299(14):1657. doi:10.1001/jama.299.14.1657-b.
JAMA | 
Commentary |  February 27, 2008
Critical Lessons From the ENHANCE Trial
Philip Greenland, MD; Donald Lloyd-Jones, MD, ScM
JAMA. 2008;299(8):953-955. doi:10.1001/jama.299.8.953.
JAMA | 
Editorial |  February 13, 2008
Academic Medical Centers and Financial Conflicts of Interest
David J. Rothman, PhD
JAMA. 2008;299(6):695-697. doi:10.1001/jama.299.6.695.
JAMA | 
Original Contribution |  February 13, 2008 FREE
Responses of Medical Schools to Institutional Conflicts of Interest
Susan H. Ehringhaus, JD; Joel S. Weissman, PhD; Jacqueline L. Sears, MPH; et al.
JAMA. 2008;299(6):665-671. doi:10.1001/jama.299.6.665.
JAMA | 
Health Agencies Update |  April 25, 2007
FDA Advisor Conflicts
JAMA. 2007;297(16):1764. doi:10.1001/jama.297.16.1764-a.
JAMA Psychiatry | 
Editorial |  November 01, 2006
Update on the Conflict of Interest Policy for the Archives
Joseph T. Coyle, MD; Stephan Heckers, MD
Arch Gen Psychiatry. 2006;63(11):1178. doi:10.1001/archpsyc.63.11.1178.
JAMA | 
Editorial |  July 12, 2006
Update on JAMA's Conflict of Interest Policy
Annette Flanagin, RN, MA; Phil B. Fontanarosa, MD, MBA; Catherine D. DeAngelis, MD, MPH
JAMA. 2006;296(2):220-221. doi:10.1001/jama.296.2.220.
JAMA | 
Original Contribution |  April 26, 2006 FREE
Financial Conflict of Interest Disclosure and Voting Patterns at Food and Drug Administration Drug Advisory Committee Meetings
Peter Lurie, MD, MPH; Cristina M. Almeida, MD, MPH; Nicholas Stine, BA; et al.
JAMA. 2006;295(16):1921-1928. doi:10.1001/jama.295.16.1921.
JAMA | 
Special Communication |  January 25, 2006
Health Industry Practices That Create Conflicts of Interest:  A Policy Proposal for Academic Medical Centers
Troyen A. Brennan, MD, MPH; David J. Rothman, PhD; Linda Blank; et al.
JAMA. 2006;295(4):429-433. doi:10.1001/jama.295.4.429.
JAMA Otolaryngology–Head & Neck Surgery | 
Editorial |  November 01, 2005
Our Approach to Addressing Potential Conflicts of Interest
John K. Niparko, MD; Paul A. Levine, MD; Michael M. E. Johns, MD
Arch Otolaryngol Head Neck Surg. 2005;131(11):943-944. doi:10.1001/archotol.131.11.943.
JAMA | 
Commentary |  September 21, 2005
Federal Funding and Supportive Policies for Research
John Edward Porter, JD
JAMA. 2005;294(11):1385-1389. doi:10.1001/jama.294.11.1385.
JAMA | 
Editorial |  July 06, 2005
Reporting Conflicts of Interest, Financial Aspects of Research, and Role of Sponsors in Funded Studies
Phil B. Fontanarosa, MD, MBA; Annette Flanagin, RN, MA; Catherine D. DeAngelis, MD, MPH
JAMA. 2005;294(1):110-111. doi:10.1001/jama.294.1.110.
JAMA | 
Commentary |  June 01, 2005
Physicians and the Investment Industry
Eric J. Topol, MD; David Blumenthal, MD, MPP
JAMA. 2005;293(21):2654-2657. doi:10.1001/jama.293.21.2654.
JAMA Psychiatry | 
Editorial |  January 01, 2005
Beginning Year 4
Arch Gen Psychiatry. 2005;62(1):14. doi:10.1001/archpsyc.62.1.14.
JAMA | 
Commentary |  December 01, 2004
Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions:  A Counterpoint
Brian L. Strom, MD, MPH
JAMA. 2004;292(21):2643-2646. doi:10.1001/jama.292.21.2643.
JAMA | 
Controversies |  December 01, 2004
Authors’ Reply to Bayer’s Response to “Potential for Conflict of Interest in the Evaluation of Suspected Adverse Drug Reactions: Use of Cerivastatin and Risk of Rhabdomyolysis”
Bruce M. Psaty, MD, PhD; Curt D. Furberg, MD, PhD; Wayne A. Ray, PhD; et al.
JAMA. 2004;292(21):2658-2659. doi:10.1001/jama.292.21.2658.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA
Medical News and Perspectives  |  April 24, 2013
HHS: Physician-Owned Device Firms a Fraud Risk
Bridget M. Kuehn, MSJ
JAMA Internal Medicine
Correction  |  April 22, 2013
Error in Figure in: “Medicaid Drug Selection Committees and Inadequate Management of Conflicts of Interest”
JAMA Internal Medicine
Evidence to Practice  |  February 25, 2013
Industry Sponsorship and Research Outcome:  A Cochrane Review
Lisa Bero, PhD
JAMA
Capitol Health Call  |  March 13, 2013
Letting the Sunshine In
Mike Mitka, MSJ
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems